Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2026-02-25 @ 8:48 PM
Study NCT ID:
NCT02138734
Status:
RECRUITING
Last Update Posted:
2025-10-16
First Post:
2014-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
Sponsor:
ImmunityBio, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-muscle Invasive Bladder Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | antitumor | View |
| None | BCG | View |
| None | bladder cancer | View |
| None | cancer | View |
| None | immunotherapy | View |
| None | instillation | View |
| None | interleukin-15 | View |
| None | intravesical | View |
| None | naive | View |
| None | non-muscle invasive | View |
| None | transitional cell carcinoma | View |
| None | ALT-803 | View |
| None | N-803 | View |